Literature DB >> 8900226

Tourette syndrome in a pedigree with a 7;18 translocation: identification of a YAC spanning the translocation breakpoint at 18q22.3.

L Boghosian-Sell1, D E Comings, J Overhauser.   

Abstract

Tourette syndrome is a neuropsychiatric disorder characterized by the presence of multiple, involuntary motor and vocal tics. Associated pathologies include attention deficit disorder and obsessive-compulsive disorder (OCD). Extensive linkage analysis based on an autosomal dominant mode of transmission with reduced penetrance has failed to show linkage with polymorphic markers, suggesting either locus heterogeneity or a polygenic origin for Tourette syndrome. An individual diagnosed with Tourette syndrome has been described carrying a constitutional (7;18) chromosome translocation (Comings et al. 1986). Other family members carrying the translocation exhibit features seen in Tourette syndrome including motor tics, vocal tics, and OCD. Since the disruption of specific genes by a chromosomal rearrangement can elicit a particular phenotype, we have undertaken the physical mapping of the 7;18 translocation such that genes mapping at the site of the breakpoint can be identified and evaluated for a possible involvement in Tourette syndrome. Using somatic cell hybrids retaining either the der(7) or the der(18), a more precise localization of the breakpoints on chromosomes 7 and 18 have been determined. Furthermore, physical mapping has identified two YAC clones that span the translocation breakpoint on chromosome 18 as determined by FISH. These YAC clones will be useful for the eventual identification of genes that map to chromosomes 7 and 18 at the site of the translocation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8900226      PMCID: PMC1914824     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  Somatic cell hybrid deletion map of human chromosome 18.

Authors:  A D Kline; K Rojas; R Mewar; D Moshinsky; J Overhauser
Journal:  Genomics       Date:  1992-05       Impact factor: 5.736

2.  9p monosomy in a patient with Gilles de la Tourette's syndrome.

Authors:  L D Taylor; D B Krizman; J Jankovic; A Hayani; P C Steuber; F Greenberg; R G Fenwick; C T Caskey
Journal:  Neurology       Date:  1991-09       Impact factor: 9.910

3.  A first-generation physical map of the human genome.

Authors:  D Cohen; I Chumakov; J Weissenbach
Journal:  Nature       Date:  1993-12-16       Impact factor: 49.962

4.  A prospective longitudinal study of Gilles de la Tourette's syndrome.

Authors:  A S Carter; D L Pauls; J F Leckman; D J Cohen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1994 Mar-Apr       Impact factor: 8.829

Review 5.  Molecular analysis of the 18q- syndrome--and correlation with phenotype.

Authors:  A D Kline; M E White; R Wapner; K Rojas; L G Biesecker; J Kamholz; E H Zackai; M Muenke; C I Scott; J Overhauser
Journal:  Am J Hum Genet       Date:  1993-05       Impact factor: 11.025

6.  Evidence for autosomal dominant transmission in Tourette's syndrome. United Kingdom cohort study.

Authors:  V Eapen; D L Pauls; M M Robertson
Journal:  Br J Psychiatry       Date:  1993-05       Impact factor: 9.319

7.  Linkage of the leuS, emtB, and chr genes on chromosome 5 in humans and expression of human genes encoding protein synthetic components in human--Chinese hamster hybrids.

Authors:  S Dana; J J Wasmuth
Journal:  Somatic Cell Genet       Date:  1982-03

Review 8.  Tic disorders.

Authors:  H S Singer
Journal:  Pediatr Ann       Date:  1993-01       Impact factor: 1.132

Review 9.  The genetics of the Gilles de la Tourette syndrome: a review.

Authors:  B J van de Wetering; P Heutink
Journal:  J Lab Clin Med       Date:  1993-05

10.  A family study of Gilles de la Tourette syndrome.

Authors:  D L Pauls; C L Raymond; J M Stevenson; J F Leckman
Journal:  Am J Hum Genet       Date:  1991-01       Impact factor: 11.025

View more
  31 in total

1.  Translocation breakpoint in two unrelated Tourette syndrome cases, within a region previously linked to the disorder.

Authors:  Fiona C Crawford; Ghania Ait-Ghezala; Mark Morris; Maxine J Sutcliffe; Robert A Hauser; Archie A Silver; Michael J Mullan
Journal:  Hum Genet       Date:  2003-04-16       Impact factor: 4.132

Review 2.  The genetics of Tourette syndrome.

Authors:  Hao Deng; Kai Gao; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2012-03-13       Impact factor: 42.937

3.  Epsilon-sarcoglycan is not involved in sporadic Gilles de la Tourette syndrome.

Authors:  Friedrich Asmus; Sarah Schoenian; Peter Lichtner; Marita Munz; Petra Mayer; Bertram Muller-Myhsok; Alexander Zimprich; Helmut Remschmidt; Johannes Hebebrand; Oliver Bandmann; Thomas Gasser
Journal:  Neurogenetics       Date:  2005-02       Impact factor: 2.660

4.  Chromosomal rearrangements in Tourette syndrome: implications for identification of candidate susceptibility genes and review of the literature.

Authors:  Birgitte Bertelsen; Nanette Mol Debes; Lena E Hjermind; Liselotte Skov; Karen Brøndum-Nielsen; Zeynep Tümer
Journal:  Neurogenetics       Date:  2013-08-29       Impact factor: 2.660

5.  Identification of chromosome 7 inversion breakpoints in an autistic family narrows candidate region for autism susceptibility.

Authors:  Holly N Cukier; David A Skaar; Melissa Y Rayner-Evans; Ioanna Konidari; Patrice L Whitehead; James M Jaworski; Michael L Cuccaro; Margaret A Pericak-Vance; John R Gilbert
Journal:  Autism Res       Date:  2009-10       Impact factor: 5.216

Review 6.  Quest for the elusive genetic basis of Tourette syndrome.

Authors:  P I Patel
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

7.  An Analytic Solution to the Computation of Power and Sample Size for Genetic Association Studies under a Pleiotropic Mode of Inheritance.

Authors:  Derek Gordon; Douglas Londono; Payal Patel; Wonkuk Kim; Stephen J Finch; Gary A Heiman
Journal:  Hum Hered       Date:  2017-03-18       Impact factor: 0.444

Review 8.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

9.  Intragenic deletions affecting two alternative transcripts of the IMMP2L gene in patients with Tourette syndrome.

Authors:  Birgitte Bertelsen; Linea Melchior; Lars R Jensen; Camilla Groth; Birte Glenthøj; Renata Rizzo; Nanette Mol Debes; Liselotte Skov; Karen Brøndum-Nielsen; Peristera Paschou; Asli Silahtaroglu; Zeynep Tümer
Journal:  Eur J Hum Genet       Date:  2014-02-19       Impact factor: 4.246

10.  Association of specific language impairment (SLI) to the region of 7q31.

Authors:  Erin K O'Brien; Xuyang Zhang; Carla Nishimura; J Bruce Tomblin; Jeffrey C Murray
Journal:  Am J Hum Genet       Date:  2003-04-29       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.